SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026474
Filing Date
2024-08-14
Accepted
2024-08-13 17:36:36
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20240630_10q.htm   iXBRL 10-Q 1465923
2 EXHIBIT 10.1 ex_709333.htm EX-10.1 154771
3 EXHIBIT 31.1 ex_676514.htm EX-31.1 13775
4 EXHIBIT 31.2 ex_676515.htm EX-31.2 13970
5 EXHIBIT 32.1 ex_676516.htm EX-32.1 7014
6 EXHIBIT 32.2 ex_676517.htm EX-32.2 7284
  Complete submission text file 0001437749-24-026474.txt   7846664

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240630.xsd EX-101.SCH 72080
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zvra-20240630_cal.xml EX-101.CAL 66457
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240630_def.xml EX-101.DEF 475234
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240630_lab.xml EX-101.LAB 439843
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240630_pre.xml EX-101.PRE 510352
82 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240630_10q_htm.xml XML 1151431
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 241203216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)